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Editor Note
Clinical pharmacology biopharmaceutics journal is a peer reviewed,
open access journal comprising active portfolio to meet the challenges
in the growing biomedical sciences.
Author Naruhashi K, et al., examined the intestinal transport
characteristics of morphine and loperamide and the role of P-gp in
their transport process. The studies were performed using Caco-2 cell
lines to assess bidirectional permeability and inhibition transport
systems.The intestinal absorption was examined by an in situ closedloop method in rats. Results of the study depict that
loperamideexhibits secretory transport across rat intestinal tissue and
Caco-2 cells, and P-gp substrates cyclosporine A and rhodamine 123
acts as an inhibitor of this transport [1].
Agabio R, et al., investigated the safety and efficacy of oxytocin nasal
spray in patients affected by binge eating disorder and obesity. Author
conducted a pilot, randomized; double-blind trial with seventeen
outpatients affected by binge eating disorder and obesity along with
placeboof an energy-restricted diet. Results of the study found to be in
line with previous literatures [2].
Review article presented by Bandameedi R., envisaged the recent
outbreak of zika virus threat for pregnant women. Recent outbreak of
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Zika virus with more pathogenic flavivirus infections created havoc in
the world;it’s a need of hour to evaluate specific screening and
diagnostic tests along with epidemiological data to rectify current
global health issues. Author stresses on the short-term actions must be
directed to combating the dissemination of vector [3].
The study evaluated the correlation between pharmacokinetics and
pharmacodynamics of thedocetaxel and CYP3A4 activity in the
Egyptian cancer patients [4].

References
1. Naruhashi K, Kamino A, Ochi E, Kusabiraki E, Ueda M, et al. (2016)

Transport Mechanism of Intestinal Absorption of μ Opioid Receptor
Agonists and Contribution of P-Glycoprotein in Rats and Human Intestinal
Epithelial Caco-2. ClinPharmacolBiopharm 5:154.
2. Agabio R, Farci AMG, Curreli O, Deidda R, Mercuro S, et al. (2016)
Oxytocin Nasal Spray in the Treatment of Binge Eating Disorder and
Obesity:
A
Pilot,
Randomized,
Double-Blind
Trial.
ClinPharmacolBiopharm 5:155.
3. Bandameedi R (2016) Recent Outbreak of Zika Virus Threat for Pregnant
Women. ClinPharmacolBiopharm 5:157.
4. Omran M, Badary O, Helal A, Shouman S (2016) A Prospective
Pharmacokinetic Study of Docetaxel in Breast Cancer Patients in Relation
to CYP3A4 Activity. ClinPharmacolBiopharm 5: 156.

Volume 5 • Issue 2 • 1000e125

